NEWS

Biotekhåb satser på at kurere diabetes

Biotekselskabet Pancryos fra København arbejder på en celleterapi, der skal kunne kurere type 1-diabetes. Folkene bag mener at have opdaget en fremgangsmåde, der kan overgå konkurrenterne på området. Read more...

Fra forsker til CEO

For fem år siden sprang Jacqueline Ameri ud som iværksætter og takkede nej til egen forskergruppe. I dag er virksomheden netop blevet optaget i det prestigefyldte Creation House-program, hvor de har fået et lån på 10 mio. kr. fra Novo Nordisk Fonden. Read more...

Entrepreneurial support for Stem Cell-Spinout from UCPH

The startup company PanCryos, which is a spinout from the Novo Nordisk Foundation Center for Stem Cell Biology at University of Copenhagen, receives a convertible loan of DKK 10 M. as well as entrepreneurial support from BioInnovation Institute, as they are enrolled...

BII funds stem cell therapy start-up with DKK 10M

The start-up PanCryos joins the Creation House program with a convertible loan of DKK 10M. Soon the company which is led by CEO and co-founder Dr. Jacqueline Ameri will move into BioInnovation Institute to continue the work on developing a new treatment for diabetes...

Immature cells zap around before settling down

Stem cells are already being used in combating previously untreatable diseases. Nevertheless, stem cells are not delivering their full potential because the production of specific cell types from stem cells cannot yet be managed. Researchers have now...

Time to cure type 1 diabetes: Danish researchers among the leaders

People with type 1 diabetes strongly depend on injecting synthetically produced insulin. However, this situation may change within a few years. Today, researchers can already recreate insulin-producing beta cells from stem cells, which can be implanted in people with...